Clinical Trial Update: Phase IV Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat Growth Hormone Deficiency Children [Phase 4]

View source ↗

Summary

This document reports a Phase IV clinical trial evaluating pegylated somatropin for growth hormone deficiency in children. The current status of the study is un…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Growth Hormone Deficiency
• Pituitary Dwarfism

Drugs mentioned

• Pegylated Somatropin (pegylated human growth hormone)

Snippet

Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. | Conditions: Dwarfism, Pituitary | Phase 4 | Status: UNKNOWN